Medica is the world's largest medical trade fair of all - with several thousand exhibitors from more than 60 nations in the exhibition halls! A wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, mobile health as well as physiotherapy/orthopaedic technology and medical consumables are presented here.
Do you want to hear about our achievements on the path to the IVDR certification?
Do you want to stay up-to-date when it comes to BioVendor Group portfolio?
Then come to our booth A92 in hall 3, where we will demonstrate our key projects for you. IVD solutions in the form of CLIA platform, a new generation of a unique immunoblot test for effective multiplex diagnostics Microblot-Array or our comprehensive sequencing solution using the NGS method, and much more!
We are looking forward to meeting you at the Medica in Düsseldorf. Your visit to our booth will be an honor and a chance for mutual enrichment.
START: 13 \ 11 \ 2023
END: 16 \ 11 \ 2023
Düsseldorf, DE
More information: www.medica-tradefair.com
Contact us: Barbora Vraná, vrana@biovendor.cz
The ECCMID conference showcased the latest findings in clinical microbiology and infectious diseases. And BioVendor Group was part of it!
Read moreA major advance in personalized medicine.
Read moreThese were the words of Michal Šteffl, Head of International Sales at TestLine, who summed up the participation of BioVendor Group companies at the most important event in the MENA region.
Read moreWe introduce to you our comprehensive and fast solution for the analysis of the CFTR gene.
Read moreIt is an annual occasion to meet our current business partners and suppliers and make new connections.
Read moreWe introduced a new tool for effective endometrial tumor analysis at the Mendel genetics conference.
Read moreBioVendor Group establishes the molecular diagnostic division BioVendor MDx.
Read moreThe most important medical fair took place in its usual autumn term from 15 to 18 November 2021 in Düsseldorf, Germany.
Read moreBioVendor developed user friendly diagnostic NGS kits with excellent analytical parameters and extremely fast processing for laboratories of any size.
Read moreBioVendor Group becomes the exclusive distributor of innovative tests to detect testicular cancer.
Read moreIntroducing the CLIA solution from BioVendor Group – an attractive portfolio of parameters, finely-tuned automation, new diagnostic possibilities.
Read moreThe prestigious Medlab Middle East 2021 show took place in Dubai from 21st to 24th June, and we couldn't miss it.
Read moreFully automated CLIA solution with diagnostic parameters from BioVendor Group
Read moreIntroducing the new BioVendor Group identity!
Read more
TEAMS internet platform
BioVendor is a proud member of strong academic-industrial consortium focused on research and development in the field of non-coding RNA diagnostics in oncology!
Read moreBioVendor is a proud member of a unique research cluster for the treatment of stroke
Read moreWe have established a new product segment within the BioVendor portfolio covering covid-19 relevant products.
Read moreWe continue to manufacture and supply in an unchanged manner!
Read moreBioVendor was a part of the largest attended laboratory expo worldwide.
Read moreNow we are getting closer to our goal - translating miRNA biomarkers from research to clinical diagnostics!
Read moreA succesful exhibition at MEDICA attracted many visitors and business partners.
Read moreBioVendor researchers evaluate “Clinical Utility of Current microRNA Detection Methods” in a BioTechniques journal article.
Read moreWe are pleased to announce that we have successfully participated in the External Quality Assessment (Referenzinstitut für Bioanalytik, survey of March 2019), being involved in determination of IL-6.
Read moreWe are so proud that BioVendor's ANGPTL3 Human ELISA participated in a major study.
Read moreGreat pleasure! We thank all who attended BioVendor seminar where MiRXES introduced GASTROClear, a diagnostic microRNA panel for Gastric cancer screening.
Read moreWe are pleased to announce that we have successfully participated in the External Quality Assessment (INSTAND, survey of March 20, 2019), being involved in determination of Cystatin C.
Read moreWe would like to invite you to a one-day expert seminar organized in cooperation with MiRXES on May 13, 2019.
Read moreBioVendor held distributor meeting in Brno with tour the laboratories and visiting unique Mendel Museum & Augustinian Abbey in Brno.
Read moreGreat to see everyone at 9th Gene Quantification Event in Freising-Weihenstephan.
Read moreBioVendor was a part of the largest attended laboratory expo worldwide.
Read more3rd Annual distributor meeting of BioVendor Group was in a new format this year.
Read moreA succesful exhibition at MEDICA attracted many visitors and business partners.
Read moreBioVendor was a part of the AACC congress in Chicago, USA.
Read moreWe will introduce BioVendor original miREIA method for microRNA quantification at the Harvard Medical School soon.
Read moreWithin the framework of our continous expansion of IVD products, we are happy to announce that further BioVendor products are now available for IVD use.
Read moreBioVendor was a part of the European Atherosclerosis Society (EAS) congress in Lisbon, Portugal.
Read moreBioVendor was a part of the largest attended laboratory expo worldwide
Read moreA succesful exhibition at MEDICA attracted many visitors and business partners
Read moreWe are proud to announce launch of the first miREIA kit.
Read moremiREIA Presented at the AACC 2017, San Diego
Read more